Clinical Trial Update: Tocilizumab in Coronavirus-19 Positive Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for tocilizumab in COVID-19 patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus
• Respiratory Syndrome Coronavirus 2

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University of Calgary | Conditions: Covid19, COVID-19 | Phase 3 | Status: UNKNOWN